BREAST CANCER: FROM MOLECULAR SIGNATURE TO CLINICAL ONCOLOGY
Targeting DNA Repair Benedetta Pellegrino
Preclinical data and translational relevance of Homologous Recombination Deficiency (HRD) in breast cancer Violeta Serra
BRCA1/2 testing: therapeutic implications for breast cancer management Daniela Boggiani
Phenotypic heterogeneity and evolution in patients with luminal breast cancer Luca Magnani
TNBC breast cancer Maria Vittoria Dieci
Luminal-like breast cancer Barbara Pistilli
HER2-positive breast cancer Filippo Montemurro